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Abstract 
Background/Objective: We have recently developed monitoring from the injury site in patients with acute, severe 
traumatic spinal cord injuries to facilitate their management in the intensive care unit. This is analogous to monitoring 
from the brain in patients with traumatic brain injuries. This study aims to determine whether, after traumatic spinal 
cord injury, fluctuations in the monitored physiological, and metabolic parameters at the injury site are causally linked 
to changes in limb power.
Methods: This is an observational study of a cohort of adult patients with motor-incomplete spinal cord injuries, i.e., 
grade C American spinal injuries association Impairment Scale. A pressure probe and a microdialysis catheter were 
placed intradurally at the injury site. For up to a week after surgery, we monitored limb power, intraspinal pressure, 
spinal cord perfusion pressure, and tissue lactate-to-pyruvate ratio. We established correlations between these vari-
ables and performed Granger causality analysis.
Results: Nineteen patients, aged 22–70 years, were recruited. Motor score versus intraspinal pressure had exponen-
tial decay relation (intraspinal pressure rise to 20 mmHg was associated with drop of 11 motor points, but little drop in 
motor points as intraspinal pressure rose further, R2 = 0.98). Motor score versus spinal cord perfusion pressure (up to 
110 mmHg) had linear relation (1.4 motor point rise/10 mmHg rise in spinal cord perfusion pressure, R2 = 0.96). Motor 
score versus lactate-to-pyruvate ratio (greater than 20) also had linear relation (0.8 motor score drop/10-point rise 
in lactate-to-pyruvate ratio, R2 = 0.92). Increased intraspinal pressure Granger-caused increase in lactate-to-pyruvate 
ratio, decrease in spinal cord perfusion, and decrease in motor score. Increased spinal cord perfusion Granger-caused 
decrease in lactate-to-pyruvate ratio and increase in motor score. Increased lactate-to-pyruvate ratio Granger-caused 
increase in intraspinal pressure, decrease in spinal cord perfusion, and decrease in motor score. Causality analysis also 
revealed multiple vicious cycles that amplify insults to the cord thus exacerbating cord damage.
Conclusion: Monitoring intraspinal pressure, spinal cord perfusion pressure, lactate-to-pyruvate ratio, and interven-
ing to normalize these parameters are likely to improve limb power.
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Introduction
Traumatic spinal cord injury (TSCI) affects about 
180,000 people globally each year [1]. Prognosis is gen-
erally poor. For example, more than a third of patients 
have paraplegia or quadriplegia, fewer than 1% are 
discharged neurologically normal and life expectancy 
is below national averages [2]. No treatment for acute 
TSCI has been proven to improve outcome: the effects 
of early surgery [3–7], intravenous methylprednisolone 
[8–12] or maintaining mean arterial pressure (MAP) 
85–90  mmHg for a week after TSCI [13–16] remain 
controversial [17].
To improve the management of patients with TSCI 
in the intensive care unit (ICU), multi-modality moni-
toring from the injury site has been suggested [18]. 
Intraspinal pressure (ISP) and spinal cord perfusion 
pressure (SCPP) [19–21] are monitored with a pressure 
probe, as well as injury site metabolism with a micro-
dialysis (MD) catheter [22, 23]. These techniques are 
safe and analogous to multi-modality monitoring for 
brain injury [24]. ISP and SCPP correlate with injury 
site metabolism [25], neurological status [26], and long-
term neurological outcome [20], and patients with neu-
rologically complete TSCIs have more deranged cord 
metabolism than those with neurologically incomplete 
injuries [22]. These relations between ISP, SCPP, and 
injury site metabolism versus neurological outcome are 
associations that do not imply causation.
The objective of our study is to address the question 
whether changes in ISP, SCPP, and injury site metabo-
lism cause changes in limb power. This is paramount 
because it implies that interventions to normalize ISP, 
SCPP, and injury site metabolism would improve limb 
power. To determine causation, we focused on grade C 
(American Spinal Injury Association Impairment Scale, 
AIS) injuries because they have some intact limb power 
below the injury. Limb motor score, ISP, SCPP, and 
injury site lactate-to-pyruvate ratio (LPR) were moni-
tored for up to a week after surgery. We used these time 
series to investigate the hypothesis that fluctuations in 
motor score are caused by fluctuations in the physiol-
ogy and metabolism at the injury site. We employed 
the concept of causality proposed by Clive Granger 
[27] and recently reviewed [28], i.e., a variable, such as 
SCPP, which evolves in time, Granger-causes another 
time-evolving variable, such as motor score, if predic-
tions of motor score based on its own past and on the 
past of SCPP are better than predictions of motor score 
based solely on its own past.
Methods
Institutional Research Board Approvals
Injured Spinal Cord Pressure Evaluation (ISCoPE) is a 
clinical study at St. George’s Hospital in London, U.K., 
registered at www.clini cal trials.gov as NCT02721615. 
Approvals for the ISCoPE study including the consent 
form and patient information sheet were obtained by the 
St. Georges Joint Research Office and the U.K. National 
Research Ethic Service—Camberwell St Giles Commit-
tee (No 10/H0807/23). The study has been performed in 
accordance with the ethical standards as laid down in the 
1964 Declaration of Helsinki and its later amendments. 
Informed consent was obtained from all individual par-
ticipants included in the study.
Study Design
We investigated the correlations and causal relations 
between ISP, SCPP, tissue LPR, glutamate, and standard-
ized motor score in AIS C TSCI patients.
Inclusion/Exclusion Criteria
We selected all AIS grade C TSCI patients who were 
enrolled into ISCoPE for the period October 2011–Janu-
ary 2020. Inclusion criteria for ISCoPE are: severe TSCI 
grades A–C, age 18–70  years and surgery performed 
within 72  h of injury. Exclusion criteria are: major co-
morbidity, inability to obtain consent, and penetrating 
TSCI. The ISCoPE study initially aimed to develop ISP 
monitoring from the injury site. In 2014, we also started 
monitoring MD. The current study includes AIS grade C 
patients who only had ISP monitoring (recruited 2011–4) 
as well as those who also had MD monitoring (recruited 
2014–2020).
Clinical Examination and Imaging
All patients were admitted to the neurosurgical unit 
at St. George’s Hospital and underwent International 
Standards for Neurological Classification of Spinal Cord 
Injury assessments by a trained neurosurgical resi-
dent, which was repeated at discharge and in follow-up 
clinic. Postoperatively, all patients were admitted to the 
Neuro-ICU. As standard clinical care in our unit, all 
TSCI patients undergo regular motor limb assessments 
by nurses trained in Medical Research Council grad-
ing of limb power. These assessments were performed 
with the patient off sedation or during a sedation hold 
and recorded in spinal assessment charts. Patients had 
CT and MRI of the spine before surgery and within four 
weeks of surgery.
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Probe Insertion
Surgical decompression and spinal instrumentation were 
performed by a neurosurgeon based on patient require-
ments and surgeon preference. Surgical decompression 
was laminectomy with or without corpectomy with spi-
nal instrumentation based on surgeon preference. Poste-
rior fixation was with lateral mass screws for the cervical 
spine and pedicle screws for the thoracic spine. Ante-
rior cervical fixation was with vertebral body plate and 
screws. During the posterior approach, a pressure probe 
(Codman Microsensor Transducer®, Depuy Synthes, 
Leeds, UK) and a MD catheter (CMA61: CMA micro-
dialysis AB, Solna, Sweden) were placed intradurally on 
the surface of the injured cord at the site of maximal 
cord swelling based on the preoperative MRI (Fig. 1). The 
dural opening was sutured and supplemented with fibrin 
glue (Tisseel®, Baxter, UK). Postoperative CT with the 
probes in situ confirmed positioning.
Intraspinal Pressure and Blood Pressure Monitoring
The pressure probe was connected to a Codman ICP box 
linked via a ML221 amplifier to a PowerLab running Lab-
Chart v.8 (AD Instruments, Oxford, UK). Blood pressure 
was recorded from a radial artery catheter connected to 
the Philips Intellivue MX800 bedside monitoring sys-
tem (Philips, Guildford, UK), in turn connected to the 
PowerLab system. ISP and blood pressure signals were 
sampled at 1  kHz, and patients were monitored for up 
to a week. Data were analyzed using Labchart version 8 
(AD Instruments, Oxford, UK) and ICM+ (www.neuro 
surg.cam.ac.uk/icmpl us). We computed SCPP as MAP–
ISP. ISP is different from intrathecal pressure measured 
above or below the injury because the swollen, injured 
cord is compressed against the dura thus compartmen-
talizing the intrathecal space as illustrated in Fig. 1a and 
described in earlier publications [29–31].
Microdialysis Setup and Analysis
MD was started postoperatively in the Neuro-ICU as 
described [22, 23, 25]. Central nervous system fluid 
(CMA microdialysis AB) was perfused at 0.3 μL/min 
using the CMA106 pump (CMA microdialysis AB). MD 
vials were changed hourly and analyzed using ISCUS 
Flex (CMA microdialysis AB) for glucose, lactate, and 
pyruvate. The LPR was calculated. The first two samples 
from each patient were discarded to allow priming of the 
MD catheter and stabilization of the metabolite concen-
trations. 100-fold changes in metabolite concentration, 
compared with the preceding hour, were excluded from 
analysis. Metabolite levels were compared to correspond-
ing hourly averages of ISP, MAP, and SCPP. Our MD 
method measures spinal cord surface metabolism at the 
injury site, which correlates with intraparenchymal injury 
site metabolism, but is different from metabolites meas-
ured from lumbar cerebrospinal fluid [22, 23, 32].
Standardization of Limb Motor Score
The motor scores in the spinal assessment charts were 
standardized by subtracting the minimum postoperative 
motor score for each patient from all motor scores for 
that patient. Standardized motor scores were compared 
to ISP, MAP, SCPP, and MD values averaged over the 
hour corresponding to the neurological assessment.
Summary of Variables/Outcomes
We obtained matched values of ISP, SCPP, tissue glucose, 
LPR, and standardized motor score. To avoid bias, data 
Fig. 1 Monitoring setup. a Intraspinal pressure probe and microdi-
alysis catheter inserted intradurally to monitor from injured cord. b 
Preoperative sagittal T2 MRI of patient no. 52 with spinal cord injury 
at C6. c. Postoperative axial CT with intraspinal pressure probe and 
microdialysis catheter in situ. d Multi-modality monitoring of motor 
score (yellow), intraspinal pressure (blue), mean arterial pressure 
(green), spinal cord perfusion pressure (red) as well as tissue glucose 
(pink), lactate (orange), pyruvate (cyan), and lactate-to-pyruvate ratio 
(purple) (Color figure online)
were analyzed blindly, i.e., each variable/outcome was 
obtained and listed for analysis without knowledge of the 
other associated variables.
Statistical Analysis
Motor score (y) versus ISP (x) was fitted with an expo-
nential decay curve y = A+ Be−Cx , motor score versus 
SCPP and versus LPR were fitted with linear equations, 
whereas motor score (y) versus MAP (x) was fitted with 
a bounded exponential curve y = A+ B(1− e−Cx) using 
the online free curve fitting service (https ://mycur vefit 
.com/). Plots are mean ± standard error. For Granger cau-
sality analysis of the standardized motor score, ISP, SCPP, 
and LPR time series, we used the Granger function in the 
Cloud Causal Analytics Toolkit (https ://cox-assoc iates 
.com/) that employs vector autoregression models to test 
for causal relations. For details, see Supplement.
Results
Participants
There were 19 patients, with average age 47 years (range 
19–70), of which 14 (74%) were male and 5 (26%) female. 
Fourteen (74%) had cervical and 5 (26%) thoracolumbar 
injuries. Of the 19 patients, 12 (63%) had posterior sur-
gical approach plus laminectomy, 5 had anterior plus 
posterior approach and laminectomy (26%) and 2 (11%) 
had posterior approach without laminectomy. Mean time 
from injury to surgery was 38 h. All 19 patients had ISP 
monitoring and 13 (68%) also had MD monitoring. The 
mean duration of ISP monitoring was 5.1  days (range 
1.8–6.8) and of MD monitoring 3.7  days (range 0–6.8). 
The mean number of motor exams in the monitored 
period was 19 (range 5–37). Table 1 has details.
Complications
Two patients (11%) had cerebrospinal fluid leak from 
around the probe skin exit site which stopped with addi-
tional sutures, and 4 patients (21%) had asymptomatic 
pseudomeningocele on the postoperative MRI. Four 
patients (21%) had chest sepsis, and 1 (5.3%) patient 
developed Korsakoff psychosis from alcohol withdrawal.
Motor Score Strongly Correlates with Injury Site Physiology
Figure 2 shows the relations between standardized motor 
score versus ISP, versus SCPP, and versus MAP using 
data from all 19 patients. The curve y = 3.9+ 33.4e−1.1x 
fits well with the relation between average motor score 
(y) versus ISP class (x = 1, …, 8, respectively, defined 
as < 5, …, 35 – 40  mmHg). Reduction in ISP from > 20 
to < 5 mmHg is associated with an average gain of about 
11 motor points, whereas fluctuations in ISP in the 
range 20–40  mmHg are not associated with changes in 
average motor score. The line y = 1.4x − 3.9 fits well 
with the relation between average standardized motor 
Table 1 Demographic details of the AIS grade C patients
Ant anterior, C cervical, F female, h hours, Lami laminectomy, L lumbar, M male, No. number, Post posterior, Pt. patient, T thoracic, y years









1 8 64 F C5 Post No 47 94 0 6
2 9 49 F C5 Post Yes 16 43 0 6
3 10 54 M T12 Post Yes 48 117 0 13
4 13 65 M C4 Post + Ant Yes 11 68 0 10
5 20 59 M C6 Post Yes 32 71 0 14
6 40 70 F C4 Post Yes 20 156 156 23
7 44 26 M T12 Post Yes 46 160 35 23
8 45 37 M C4 Post + Ant Yes 29 136 138 25
9 50 63 M C7 Post Yes 47 105 0 12
10 52 19 M C6 Post Yes 41 145 145 28
11 54 63 M C5 Post Yes 58 138 137 25
12 61 56 F L1 Post Yes 31 114 161 27
13 66 67 M C4 Post No 38 160 157 25
14 67 32 M C4 Post + Ant Yes 22 159 163 35
15 68 37 F L3 Post Yes 23 139 125 22
16 70 35 M C4 Post + Ant Yes 39 112 109 5
17 71 27 M L1 Post Yes 41 144 145 37
18 81 54 M C4 Post Yes 69 161 150 25
19 84 22 M C6 Post + Ant Yes 70 84 82 5
score (y) versus SCPP class (x = 1, …, 7, respectively, 
defined as 40–50, …, 100–110 mmHg). Increasing SCPP 
from < 50  mmHg, up to 110  mmHg, is associated with 
an average gain of about 8–9 motor points. Increasing 
SCPP beyond 110 mmHg is associated with a reduction 
in motor score. The curve y = −0.1+ 6.0(1− e−0.4x) 
fits well with the relation between average standardized 
motor score (y) versus MAP class (x = 1, …, 11, respec-
tively, defined as < 75, …, > 120 mmHg). Increase in MAP 
from < 75 to 95 mmHg is associated with an average gain 
of about 4 motor points, whereas fluctuations in MAP in 
the range 95–130 mmHg are not associated with changes 
in average standardized motor score.
Motor Score Strongly Correlates with Injury Site 
Metabolism
Figure 3 shows that the line y = −0.8x + 8.3 fits well with 
the relation between average standardized motor score 
(y) versus LPR class (x = 2, …, 6, respectively, defined as 
20–30, …, > 70), plotted using data from the 13 patients 
who had MD monitoring. Reducing the LPR from > 70 
to 20–30 is associated with an average gain of about 4 
motor points. Reducing the LPR below 20 is associated 
with a reduction in average standardized motor score. 
Increasing the LPR from 20–30 to 30–40 was associated 
with no change in pyruvate but increase in lactate. As 
LPR increases beyond 50, both pyruvate and lactate drop.
Injury Site Physiology and Metabolism Are Closely Related
Figure  4 shows how ISP is related to injury site metab-
olism. LPR (y) and ISP class (x = 1, …, 9, respectively, 
defined as < 5, …, > 40  mmHg) positively correlate 
according to y = 5.0x + 20.5 . As ISP increases, glucose 
increases, whereas lactate and pyruvate fall. Figure  5 
shows how SCPP is related to injury site metabolism. 
LPR (y) and SCPP class (x = 1, …, 8, respectively, defined 
as < 60, …, > 120 mmHg) negatively correlate according to 
y = −4.3x + 54.3 . As SCPP increases up to 110 mmHg, 
glucose remains constant, whereas lactate and pyruvate 
slightly increase. As SCPP increases beyond 110 mmHg, 
glucose and pyruvate rise, whereas lactate falls.
Causality Analysis
Granger-causal relations between the motor score, 
ISP, SCPP, and LPR time series are illustrated in Fig.  6. 
Increasing LPR Granger-causes increased ISP, decreased 
SCPP, and decreased motor score. In other words, worse 
injury site metabolism increases cord swelling, reduces 
cord perfusion, and increases limb weakness. Increas-
ing SCPP Granger-causes decreased LPR and increased 
motor score. In other words, improving spinal cord per-
fusion improves spinal cord metabolism and improves 
limb weakness. Increasing ISP Granger-causes increased 
LPR, decreased SCPP, and decreased motor score. In 
other words, increased cord swelling reduces cord per-




We showed that, after spinal cord injury, fluctuations in 
injury site physiology (cord edema, cord perfusion) and 
metabolism (LPR) Granger-cause fluctuations in limb 
power. These causal relations between events at the 
Fig. 2 Standardized motor score correlates with injury site physiology. Standardized motor score versus a intraspinal pressure, b spinal cord perfu-
sion pressure and c mean arterial pressure. Mean ± standard error. Trends (dotted gray line) modeled as exponential decay (intraspinal pressure, 
R2 = 0.98, P < 0.0005), linear (spinal cord perfusion pressure in the range < 50 to 110 mmHg, R2 = 0.96, P < 0.0005), and bounded exponential (Mean 
arterial pressure, R2 = 0.73, P < 0.05)
injury site and limb power were established by monitor-
ing patients with acute, motor-incomplete spinal cord 
injuries.
Limitations
Though the study has a relatively small number of 
patients (19), our conclusions are supported by a large 
amount of monitoring data including 2,306 h of ISP and 
SCPP monitoring, 1,703  h of MD monitoring and 366 
motor examinations. Another issue is that causality is a 
deeply philosophical concept with many possible answers 
that do not satisfy everyone, compared with our defini-
tion of causality, which is purely mathematical.
Granger Causality
Establishing causation in medicine is based on the total-
ity of evidence that includes strong association, biologi-
cal mechanism, consistent finding, temporal sequence, 
Fig. 3 Standardized motor score correlates with injury site 
metabolism. a Relation between standardized motor score and 
lactate-to-pyruvate ratio. b Glucose and c Lactate + Pyruvate versus 
lactate-to-pyruvate ratio. Mean ± standard error. In a, the dotted line 
is the best fit straight line for lactate-to-pyruvate ratio in the range 20 
to > 70 mmHg, R2 = 0.92, P < 0.005
Fig. 4 Intraspinal pressure correlates with injury site metabolism. a 
Tissue glucose, b tissue lactate-to-pyruvate ratio and c tissue pyru-
vate (black) + lactate (gray), versus Intraspinal pressure. Mean ± stand-
ard error. In a, best fit straight line R2 = 0.57, P < 0.05
and dose–response [33]. In the absence of a randomized 
trial, which is considered the “gold standard” to estab-
lish causation [34, 35], we investigated causal relations 
in our observational data using Granger analysis [27, 28]. 
Granger’s definition of causality, initially developed for 
financial forecasting, satisfies two intuitive notions: First, 
the cause always precedes the effect. Second, the cause 
carries unique information about the future effect, i.e., 
there is information flow from the past of the cause to the 
future of the effect that cannot be accounted for by the 
past of the effect. Implicit in these notions is that inter-
vention to alter the cause should result in a predictable 
change in the future of the effect. Advantages of Granger 
are that it is expressed in relatively straightforward 
mathematics that permit hypothesis testing and provide 
information about the strength of each causality [34, 35]. 
Alternative analyses that can distinguish between causa-
tion and correlation may be performed, e.g., convergent 
cross mapping, which is based on complexity theory and, 
unlike Granger, does not assume linear relations [36].
Interpretation of Correlations
Multiple correlations between injury site physiology, 
metabolism, and neurological status were defined. Here, 
we highlight some interesting findings: First, optimal ISP 
is less than 5 mmHg, i.e., no cord compression. Second, 
increase in ISP from 20 to 40 mmHg is associated with 
increase in LPR, but no reduction in limb power, prob-
ably because the standardized motor score is already 
very low. Third, as SCPP increases, LPR decreases 
(less ischemia) and limb power improves but, beyond 
110 mmHg, limb power decreases, suggesting that hyper-
perfusing the injury site is detrimental. Metabolically, 
hyper-perfusion is characterized by very low (less than 
20) LPR and high glucose; though this is aerobic metabo-
lism, our data suggest that the high glucose is detrimental 
as previously reported [37–39] due to increased endo-
plasmic reticulum stress, inflammation and free radi-
cals. Fourth, increasing the MAP beyond 85–90 mmHg, 
which remarkably corresponds to the recommended tar-
get [40], does not improve limb power. A possible expla-
nation is that low MAP indicates injury site ischemia 
Fig. 5 Spinal cord perfusion pressure correlates with injury site 
metabolism. a Tissue glucose. b Tissue lactate-to-pyruvate ratio and 
c. tissue pyruvate (black) + lactate (gray), versus ISP. Mean ± standard 
error. In a, best fit straight line R2 = 0.83, P < 0.005
Fig. 6 Granger causality relations. Each arrow indicates the direction 
of information flow, i.e., causal influence, with corresponding F and 
P values. ‘ + ’ or ‘–’ indicate the correlation between the variables. 
Causality arrows are shown if P < 0.05. Analysis is shown for lag = 1, 
but also holds for lag = 2 or 3. For details, see supplement
regardless of ISP, but above 90  mmHg, the same MAP 
corresponds to injury site ischemia in some patients and 
hyper-perfusion in others. In practical terms, increasing 
the SCPP improves limb power more than increasing the 
MAP. Fifth, the correlations between ISP and SCPP ver-
sus limb power are reminiscent of similar relations versus 
neurological improvement at 9–12  months [20]. Sixth, 
though there is inverse correlation between LPR and limb 
power, LPR below 20 appears detrimental likely related to 
hyper-perfusion state described above. Seventh, as LPR 
increases up to 50–60, pyruvate decreases and lactate 
increases (indicating compensatory switch from aerobic 
to anaerobic metabolism at the injury site), but as LPR 
increases beyond 60, both pyruvate and lactate decrease 
(indicating overall suppression of aerobic and anaerobic 
metabolism). Though the findings described here provide 
a unique insight into how spinal cord physiological and 
metabolic events relate to limb power, they are associa-
tions that do not imply causations.
Interpretation of Causal Effects
The causal relations between LPR, SCPP, ISP, and stand-
ardized motor score in Fig.  6 make biological sense. 
A metabolic insult (high LPR, e.g., from hypoxia or 
infection) Granger-causes cord swelling (high ISP), 
Granger-causes reduction in cord perfusion, and 
Granger-causes impaired neuronal function (reduced 
motor score). Increase in spinal cord perfusion Granger-
causes increase in aerobic metabolism at the injury site 
(decreased LPR) and Granger-causes the motor score to 
improve. Cord swelling (increase in ISP) Granger-causes 
more anaerobic metabolism (LPR increases), Granger-
causes drop in SCPP (= MAP – ISP) and Granger-causes 
reduction in limb power. Interestingly, Granger analysis 
did not produce absurdities, e.g., change in limb power 
Granger-causes physiological or metabolic changes at the 
injury site. A key finding in Fig. 6 is several positive feed-
back loops (vicious cycles), e.g., increased LPR Granger-
causes increased cord swelling, in turn Granger-causing 
increase in LPR. Multi-step vicious cycles are also evi-
dent, e.g., increased LPR Granger-causes increased cord 
swelling, which Granger-causes decreased SCPP, in turn 
Granger-causing increase in LPR. The presence of so 
many vicious cycles implies that insults to the injury site 
(e.g., hypoxia, acidosis, etc.) are amplified, thus empha-
sising the importance of treating such insults to prevent 
secondary cord damage.
Implications for Treatment
ISP is increased by cord compression from bone fragments, 
hematoma, and dura. Decompression of the injured cord 
including duroplasty would reduce ISP [41]. MAP may 
be increased using vasopressors [30]. Reducing ISP and 
increasing MAP will, in turn, increase SCPP. Interventions 
to reduce LPR (other than reducing ISP and increasing 
SCPP) include management of hypoxia, fever, and acidosis 
(e.g., limiting blood loss during surgery) [21, 32].
Generalizability
To study the relations between physiological/metabolic 
events at the injury site and limb power, we focused 
here only on AIS C TSCI patients. Our key conclusion 
that reducing ISP, increasing SCPP, and reducing LPR 
improve neurological status is likely to apply to all injury 
severities. Future studies may explore this further, e.g., 
by determining the effect of increasing SCPP on sensory 
level in AIS A and B TSCI patients.
Conclusions
The causal relationships described here suggest that 
interventions to normalize LPR, SCPP, and ISP are likely 
to improve limb power in AIS C TSCI patients.
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